Perioperative Coagulation Management and Point-of-Care Monitoring in Anesthesia

  • Gianni BiancofioreEmail author


Hemostatic function is critical in determining patient outcomes in emergency or elective surgery. Conventional coagulation tests have shown to be limited in detecting hemostatic dysfunctions and proved ineffective in diagnosing hyperfibrinolysis. Therefore, the traditional laboratory tests do not supply enough information to diagnose and treat patients timely and according to their phenotype. The viscoelastic hemostatic assays are potentially useful point-of-care tools that provide information on clot formation, clot strength, and fibrinolysis, as well as to guide goal-directed transfusion and antifibrinolytic therapy demonstrating to ameliorate treatment of acute hemorrhage in terms of decreased amount of transfusion and lowered costs. In fact, viscoelastic hemostatic assays, as compared with conventional coagulation tests, showed better for detecting coagulopathy and are the only tests that can provide rapid diagnosis of hyperfibrinolysis. Goal-directed administration of blood products based on the results of viscoelastic hemostatic assays was associated with reduction in allogeneic blood product transfusions in trauma, cardiac surgery, and liver transplantation cases. The aim of this review is to report the basic principles of the current point-of-care coagulation analyzers, to outline their clinical use, and to evaluate their ability to monitor different pharmacological substances interacting with hemostasis in the perioperative setting.


Coagulation Transfusion Patient blood management Thromboelastography Point-of-care system Surgery Anesthesia 


  1. 1.
    Turan A, Yang D, Bonilla A, et al. Morbidity and mortality after massive transfusion in patients undergoing non-cardiac surgery. Can J Anesth. 2013;60:761–70.CrossRefGoogle Scholar
  2. 2.
    Hall T, Pattenden C, Hollobine C, et al. Blood transfusion policies in elective general surgery: how to optimise cross-match-to-transfusion ratios. Transfus Med Hemother. 2013;40:27–31.CrossRefGoogle Scholar
  3. 3.
  4. 4.
    Isbister JP. The three-pillar matrix of patient blood management—an overview. Best Pract Res Clin Anaesth. 2013;27:69–84.CrossRefGoogle Scholar
  5. 5.
    Tanczos K, Nemeth M, Molnar Z. What’s new in hemorrhagic shock? Intensive Care Med. 2015;41:712–4.CrossRefGoogle Scholar
  6. 6.
    Levy J, Dutton R, Hemphill J, et al. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg. 2010;110:354–64.CrossRefGoogle Scholar
  7. 7.
    Haas T, Fries D, Tanaka K, et al. Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? Br J Anaesth. 2015;114:217–24.CrossRefGoogle Scholar
  8. 8.
    Hartmann M, Szalai C, Saner FH. Hemostasis in liver transplantation: pathophysiology, monitoring, and treatment. World J Gastroenterol. 2016;28(22):541–1550.Google Scholar
  9. 9.
    Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010;116:878–85.CrossRefGoogle Scholar
  10. 10.
    Clevenger B, Mallett SV. Transfusion and coagulation management in liver transplantation. World J Gastroenterol. 2014;20:6146–58.CrossRefGoogle Scholar
  11. 11.
    Saner FH, Kirchner C. Monitoring and treatment of coagulation disorders in end-stage liver disease. Visc Med. 2016;32:241–8.CrossRefGoogle Scholar
  12. 12.
    Noval-Padillo JA, León-Justel A, Mellado-Miras P, et al. Introduction of fibrinogen in the treatment of hemostatic disorders during orthotopic liver transplantation: implications in the use of allogenic blood. Transplant Proc. 2010;42:2973–4.CrossRefGoogle Scholar
  13. 13.
    Kozek-Langenecker S, Sørensen B, Hess JR, Spahn DR. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care. 2011;15:R239.CrossRefGoogle Scholar
  14. 14.
    Kirchner C, Dirkmann D, Treckmann JW, et al. Coagulation management with factor concentrates in liver transplantation: a single-center experience. Transfusion. 2014;54:2760–8.CrossRefGoogle Scholar
  15. 15.
    Cerutti E, Stratta C, Romagnoli R, et al. Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl. 2004;10:289–94.CrossRefGoogle Scholar
  16. 16.
    De Pietri L, Montalti R, Begliomini B, Scaglioni G, et al. Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagulability, hypocoagulability or normocoagulability? Eur J Anaesthesiol. 2010;27:608–16.CrossRefGoogle Scholar
  17. 17.
    Besser MW, Ortmann E, Klein AA. Haemostatic management of cardiac surgical haemorrhage. Anaesthesia. 2015;70(Suppl. 1):87–95.CrossRefGoogle Scholar
  18. 18.
    Johansson PI, Solbeck S, Genet G, et al. Coagulopathy and hemostatic monitoring in cardiac surgery: an update. Scand Cardiovasc J. 2012;46:194–202.CrossRefGoogle Scholar
  19. 19.
    Wikkelsø A, Wetterslev J, Møller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst Rev. 2016;(8):CD007871.Google Scholar
  20. 20.
    Deppe AC, Weber C, Zimmermann J, et al. Point-of-care thromboelastography/thromboelastometry-based coagulation management in cardiac surgery: a meta-analysis of 8332 patients. J Surg Res. 2016;203:424–33.CrossRefGoogle Scholar
  21. 21.
    Spalding GJ, Hartrumpf M, Sierig T, et al. Cost reduction of perioperative coagulation management in cardiac surgery: value of ‘bedside’ thrombelastography (ROTEM). Eur J Cardiothorac Surg. 2007;31:1052–7.CrossRefGoogle Scholar
  22. 22.
    Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth. 2001;86:575–8.CrossRefGoogle Scholar
  23. 23.
    Detecting, managing and monitoring haemostasis: viscoelastometric point-of-care testing (ROTEM, TEG and Sonoclot systems). 2014. Accessed 4 Nov 2018.
  24. 24.
    Ortmann E, Klein AA, Sharples LD, et al. Point-of-care assessment of hypothermia and protamine-induced platelet dysfunction with multiple electrode aggregometry Multiplate(R) in patients undergoing cardiopulmonary bypass. Anesth Analg. 2013;116:533–40.CrossRefGoogle Scholar
  25. 25.
    Hanke AA, Roberg K, Monaca E, et al. Impact of platelet count on results obtained from multiple electrode platelet aggregometry (Multiplate). Eur J Med Res. 2010;15:214–9.CrossRefGoogle Scholar
  26. 26.
    Reece MJ, Klein AA, Salviz EA, et al. Near-patient platelet function testing in patients undergoing coronary artery surgery: a pilot study. Anaesthesia. 2011;66:97–103.CrossRefGoogle Scholar
  27. 27.
    Ortmann E, Besser MW, Klein AA. Antifibrinolytic agents in current anaesthetic practice. Br J Anaesth. 2013;111:549–63.CrossRefGoogle Scholar
  28. 28.
    de Lange NM, Lancé MD, de Groot R, et al. Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstet Gynecol Surv. 2012;67:426–35.CrossRefGoogle Scholar
  29. 29.
    Sentilhes L, Merlot B, Madar H, Sztark F, Brun S, Deneux-Tharaux C. Postpartum haemorrhage: prevention and treatment. Expert Rev Hematol. 2016;9:1043–61.CrossRefGoogle Scholar
  30. 30.
    Karlsson O, Jeppsson A, Hellgren M. Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? Int J Obstet Anesth. 2014;23:10–7.CrossRefGoogle Scholar
  31. 31.
    Bolte A, Hermans F, Van Rheneen-Flach L, et al. Thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) in pregnancy: a systematic review. Pregnancy Hypertens. 2015;5:114–5.CrossRefGoogle Scholar
  32. 32.
    Shreeve NE, Barry JA, Deutsch LR, et al. Changes in thromboelastography parameters in pregnancy, labor, and the immediate postpartum period. Int J Gynaecol Obstet. 2016;134:290–3.CrossRefGoogle Scholar
  33. 33.
    Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth. 2012;109:851–63.CrossRefGoogle Scholar
  34. 34.
    Collis R, Guasch E. Managing major obstetric haemorrhage: pharmacotherapy and transfusion. Best Pract Res Clin Anaesthesiol. 2017;31:107–24.CrossRefGoogle Scholar
  35. 35.
    Gonzalez E, Pieracci FM, Moore EE, et al. Coagulation abnormalities in the trauma patient: the role of point-of-care thromboelastography. Semin Thromb Hemost. 2010;36:723–37.CrossRefGoogle Scholar
  36. 36.
    Da Luz LT, Nascimento B, Shankarakutty AK, et al. Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit Care. 2014;18:518.CrossRefGoogle Scholar
  37. 37.
    Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100.CrossRefGoogle Scholar
  38. 38.
    Hunt H, Stanworth S, Curry N, et al. Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding. Cochrane Database Syst Rev. 2015;2:CD010438.Google Scholar
  39. 39.
    Larsen OH, Fenger-Eriksen C, Christiansen K, et al. Diagnostic performance and therapeutic consequence of thromboelastometry activated by kaolin versus a panel of specific reagents. Anesthesiology. 2011;115:294–302.CrossRefGoogle Scholar
  40. 40.
    Lancé MD. A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Thromb J. 2015;13:1.CrossRefGoogle Scholar
  41. 41.
    Kitchen DP, Kitchen S, Jennings I, et al. Quality assurance and quality control of thrombelastography and rotational thromboelastometry: the UK NEQAS for blood coagulation experience. Semin Thromb Hemost. 2010;36:757–63.CrossRefGoogle Scholar
  42. 42.
    Chitlur M, Sorensen B, Rivard GE, et al. Standardization of thromboelastography: a report from the TEG-ROTEM working group. Haemophilia. 2011;17:532–7.CrossRefGoogle Scholar
  43. 43.
    Yeung MC, Tong S, Tong P, et al. Use of viscoelastic haemostatic assay in emergency and elective surgery. Hong Kong Med J. 2015;21:45–51.PubMedGoogle Scholar
  44. 44.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Transplant Anesthesia and Critical CareUniversity School of MedicinePisaItaly

Personalised recommendations